Center for Neuroscience.
Neuroscience Graduate Group and.
J Neurosci. 2018 May 9;38(19):4462-4470. doi: 10.1523/JNEUROSCI.0394-18.2018. Epub 2018 Mar 28.
NMDA receptors (NMDARs) mediate both long-term potentiation and long-term depression (LTD) and understanding how a single receptor can initiate both phenomena remains a major question in neuroscience. A prominent hypothesis implicates the NMDAR subunit composition, specifically GluN2A and GluN2B, in dictating the rules of synaptic plasticity. However, studies testing this hypothesis have yielded inconsistent and often contradictory results, especially for LTD. These inconsistent results may be due to challenges in the interpretation of subunit-selective pharmacology and in dissecting out the contributions of differential channel properties versus the interacting proteins unique to GluN2A or GluN2B. In this study, we address the pharmacological and biochemical challenges by using a single-neuron genetic approach to delete NMDAR subunits in conditional knock-out mice. In addition, the recently discovered non-ionotropic nature of NMDAR-dependent LTD allowed the rigorous assessment of unique subunit contributions to NMDAR-dependent LTD while eliminating the variable of differential charge transfer. Here we find that neither the GluN2A nor the GluN2B subunit is strictly necessary for either non-ionotropic or ionotropic LTD. NMDA receptors are key regulators of bidirectional synaptic plasticity. Understanding the mechanisms regulating bidirectional plasticity will guide development of therapeutic strategies to treat the dysfunctional synaptic plasticity in multiple neuropsychiatric disorders. Because of the unique properties of the NMDA receptor GluN2 subunits, they have been postulated to differentially affect synaptic plasticity. However, there has been significant controversy regarding the roles of the GluN2 subunits in synaptic long term depression (LTD). Using single-neuron knock-out of the GluN2 subunits, we show that LTD requires neither GluN2A nor GluN2B.
NMDA 受体 (NMDAR) 介导长时程增强和长时程抑制 (LTD),理解单个受体如何引发这两种现象仍然是神经科学的一个主要问题。一个突出的假设涉及 NMDAR 亚基组成,特别是 GluN2A 和 GluN2B,决定了突触可塑性的规则。然而,测试这一假设的研究产生了不一致且经常相互矛盾的结果,尤其是对于 LTD。这些不一致的结果可能是由于亚基选择性药理学的解释和区分差异通道特性与 GluN2A 或 GluN2B 特有的相互作用蛋白的贡献方面的挑战所致。在这项研究中,我们通过使用单神经元遗传方法在条件敲除小鼠中删除 NMDAR 亚基来解决药理学和生物化学方面的挑战。此外,最近发现的 NMDAR 依赖性 LTD 的非离子型特性允许严格评估独特的亚基对 NMDAR 依赖性 LTD 的贡献,同时消除了差异电荷转移的变量。在这里,我们发现 GluN2A 和 GluN2B 亚基都不是非离子型或离子型 LTD 的严格必要条件。NMDA 受体是双向突触可塑性的关键调节因子。了解调节双向可塑性的机制将指导开发治疗策略,以治疗多种神经精神疾病中功能失调的突触可塑性。由于 NMDA 受体 GluN2 亚基的独特特性,它们被假设为对突触可塑性产生不同的影响。然而,GluN2 亚基在突触长时程抑制 (LTD) 中的作用一直存在很大争议。通过单神经元敲除 GluN2 亚基,我们表明 LTD 既不需要 GluN2A 也不需要 GluN2B。